Halozyme Therapeutics Cash on Hand 2010-2024 | HALO

Halozyme Therapeutics cash on hand for the quarter ending September 30, 2024 was $0.666B, a 37.87% increase year-over-year.

  • Halozyme Therapeutics cash on hand for 2023 was $0.336B, a 7.39% decline from 2022.
  • Halozyme Therapeutics cash on hand for 2022 was $0.363B, a 51.03% decline from 2021.
  • Halozyme Therapeutics cash on hand for 2021 was $0.741B, a 101.33% increase from 2020.

Halozyme Therapeutics Cash on Hand 2010-2024 | HALO

  • Halozyme Therapeutics cash on hand for 2023 was $0.336B, a 7.39% decline from 2022.
  • Halozyme Therapeutics cash on hand for 2022 was $0.363B, a 51.03% decline from 2021.
  • Halozyme Therapeutics cash on hand for 2021 was $0.741B, a 101.33% increase from 2020.